|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
research-article |
a Department of Pathology, College of Medicine, The Catholic University, Seoul, Korea;
b The Seoul Cord Bank, Histostem Co., Ltd, Seoul, Korea;
c Laboratory of Stem Cell and Tumor Biology, Department of Veterinary Public Health,
d Department of Veterinary Radiology, College of Veterinary Medicine, Seoul National University, Seoul, Korea;
e Department of Surgery, College of Medicine, Hanyang University, Seoul, Korea
Key Words. Cord blood • Mesenchymal stem cells • Buergers disease • Cell transplantation
Correspondence: Kyung-Sun Kang, Ph.D., Laboratory of Stem Cell and Tumor Biology, Department of Veterinary Public Health, College of Veterinary Medicine, Seoul National University, Seoul, Korea. Telephone: 82-2-880-1246; Fax: 82-2-876-7610; e-mail: kangpub{at}snu.ac.kr; Hwon-Kyum Park, M.D., Ph.D., Department of Surgery, College of Medicine, Hanyang University, Seoul, Korea. Telephone: 82-31-560-2290; Fax: 82-31-566-4409; e-mail: hkpark{at}hanyang.ac.kr
Received August 4, 2005;
accepted for publication February 15, 2006.
Buergers disease, also known as thromboangiitis obliterans, is a nonatherosclerotic, inflammatory, vasoocclusive disease. It is characterized pathologically as a panangiitis of medium and small blood vessels, including both arteries and adjacent veins, especially the distal extremities (the feet and the hands). There is no curative medication or surgery for this disease. In the present study, we transplanted human leukocyte antigen-matched human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) into four men with Buergers disease who had already received medical treatment and surgical therapies. After the stem cell transplantation, ischemic rest pain suddenly disappeared from their affected extremities. The necrotic skin lesions were healed within 4 weeks. In the follow-up angiography, digital capillaries were increased in number and size. In addition, vascular resistance in the affected extremities, compared with the preoperative examination, was markedly decreased due to improvement of the peripheral circulation. Because an animal model of Buergers disease is absent and also to understand human results, we transplanted human UCB-derived MSCs to athymic nude mice with hind limb ischemia by femoral artery ligation. Up to 60% of the hind limbs were salvaged in the femoral artery-ligated animals. By in situ hybridization, the human UCB-derived MSCs were detected in the arterial walls of the ischemic hind limb in the treated group. Therefore, it is suggested that human UCB-derived MSC transplantation may be a new and useful therapeutic armament for Buergers disease and similar ischemic diseases.
This article has been cited by other articles:
![]() |
S. Ishikane, S. Ohnishi, K. Yamahara, M. Sada, K. Harada, K. Mishima, K. Iwasaki, M. Fujiwara, S. Kitamura, N. Nagaya, et al. Allogeneic Injection of Fetal Membrane-Derived Mesenchymal Stem Cells Induces Therapeutic Angiogenesis in a Rat Model of Hind Limb Ischemia Stem Cells, October 1, 2008; 26(10): 2625 - 2633. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Partlow, J. Chen, J. A. Brant, A. M. Neubauer, T. E. Meyerrose, M. H. Creer, J. A. Nolta, S. D. Caruthers, G. M. Lanza, and S. A. Wickline 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons FASEB J, June 1, 2007; 21(8): 1647 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Puechal and J.-N. Fiessinger Thromboangiitis obliterans or Buerger's disease: challenges for the rheumatologist Rheumatology, February 1, 2007; 46(2): 192 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. He, C. Wan, and G. Li Concise Review: Multipotent Mesenchymal Stromal Cells in Blood Stem Cells, January 1, 2007; 25(1): 69 - 77. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
